The expression of GAS5 was increased in PTX-resistant MDA-231-PTX and BT549-PTX cells, as well as in CIS-resistant MDA-231-CIS and BT549-CIS, compared to the parental cells. Here, GAS5 is linked to in situ carcinoma.